Can’t remember how long its been since BB was up 3.6% AH. May not seem like a lot but its been so narrow for so long. Long term BB will hit +$50 easy. They’re years ahead of any other company when it comes to cyber security. You guys who whine about the stock price and Chen know nothing about what it takes to run a company let alone turn a company around from brink of bankruptcy to being a pioneer of security infrastructure.$BlackBerry(BB)$

Would like to pick up some more. Sooner or later this is going to break out to the upside the closer we get to qtr end. Everything still looks to be on track for the market debut. Valuation has dropped a little to 39.6 billion due to GRABS ride hailing being hampered by COVID-19. But the food delivery side is doing quite well. GLTA…$Altimeter Growth Corp.(AGC)$

Clover is gonna go UP, but first it needs to fund a bottom, before it goes to 60 and UP. None other than Alphabet - the parent company of Google and Walgreens are investors. Walgreens will wind up buying Clover, just like SVS bought Aetna.In 2019 Clover was $ 450M company, its now $ 859M firm.. Last year in pandemic CLOV had 50000 customers, it now has 66K subscribers.They need a good CFO to bring costs down.$Clover Health Corp(CLOV)$

$Gevo(GEVO)$ Everyone is focused on the Chevron news, but they also just filed for a $500m shelf yesterday. I'm selling now and will buy back in after the dilution.

$Novavax(NVAX)$ The Serum Institute is expanding its Novavax production capacity by a billion doses. Novavax is buying these on a per dose basis, so it keeps all of the profits.Novavax achieved its goal of 100M doses per month in Q3, and is on track to achieve its goal of 150M by December. This indicates 600M doses in 2021.9 EUA filings have been done, covering most of the world. The vaccine has been approved by the 4th largest country, Indonesia, and many more approvals are expected soon.The UK has already inspected and certified the SII factories, indicating it will likely give approval soon. Most countries in the world accept UK approvals.With 2.1 billion in orders and likely 2022 revenues of $22B , this is highly undervalued and one of the strong

For educational purposes only I would like to call your attention to a claim made here yesterday that AAPL would hit a high price yesterday or today, which it did not.This claim was made by someone who makes a lot of claims here. So many, in fact, that it becomes entirely possible that sometimes they will end up right. But that does not mean they actually have a special ability to make predictions about a stock’s short term performance. No one does.I need to repeat that: no one can predict the short term performance of a stock. You can make lots of educated guesses, and sometimes you’ll be right and most of the time you’ll be wrong. But you don’t know. It’s not a true prediction. Please use good judgement when entertaining these people’s predictions. Otherwise you can end up making some ve

$AMC Entertainment(AMC)$ Me and the wife went to see Free Guy Saturday and the theater we were in was still over half full! Theater goers are back WOO HOO!!

Many analysts warned market may have bubbles and big corrections may happen?  AMD could drop more if Nasdaq corrects more!In a situation like this, I have to remind myself about Peter Lynch's famous quotes:  (1) A price drop for a good prospect stock is an opportunity to buy more at cheaper prices. (2) Invest in companies which have good earnings prospects, financial condition, competitive position, etc.(3) Stand by your stocks as long as the "fundamental story" of the company hasn't changed!AMD certainly is the right candidate for that! I am sure there will be many "new millionairs" created for those who know how to take advantage of this correction!As Lusa Su said "The best is yet to come!" GLTA (longs & smart shorts)! $AMD(

$BioNTech SE(BNTX)$ there is some serious stop hunting going on today, nvax$Novavax(NVAX)$ trading was even halted. we are all going on a nearly equal pattern again. DONT USE STOP LOSSES

$100 by year end. Too many payment options out there. V$Visa(V)$ is in a secular decline.